HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morphologic changes of apoptosis induced in human chronic myelogenous leukemia "blast" cells by SC41661A (Searle), a selective inhibitor of 5-lipoxygenase.

Abstract
Several inhibitors of the arachidonic acid-metabolizing enzyme, 5-lipoxygenase reduce proliferation of hematopoietic and non-hematopoietic cells and cell lines and some cells undergo limited differentiation. Cells were cultured from patients with chronic myelogenous leukemia in "blast" crisis with the selective inhibitor of 5-lipoxygenase, SC41661A[3-(3,5-bis(1,1-dimethyl)-4-hydroxyphenyl)hiol]-N-me thyl-N-[2-(2- phridinyl-propanamide)]. Cells cultured for 3 to 5 days with 40 microM SC41661A exhibited reduced cellular numbers along with ultrastructural changes and DNA laddering characteristic of apoptosis. Similar culture conditions reduced proliferation of U937 monoblastoid cells. In U937 cells, the ultrastructural features of apoptosis were not observed at 72 hours, when DNA laddering was present and cell numbers were reduced, but was present after 144 hours of culture. Dissociation between certain morphologic and biochemical sequelae of apoptosis has been described in other systems. These observations are of interest since the induction of apoptosis in dividing chronic myelogenous leukemia (CML) cells by a non-cytotoxic agent suggests paradigmatically new sites for therapeutic intervention.
AuthorsK M Anderson, T M Seed, J Peng, A Jajeh, J Meng, J E Harris
JournalScanning microscopy (Scanning Microsc) Vol. 8 Issue 3 Pg. 675-84; discussion 684-6 ( 1994) ISSN: 0891-7035 [Print] United States
PMID7747166 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Amides
  • Chromatin
  • DNA, Neoplasm
  • Lipoxygenase Inhibitors
  • Pyridines
  • SC 41661A
Topics
  • Amides (pharmacology)
  • Apoptosis (drug effects)
  • Cell Death (drug effects)
  • Cell Division (drug effects)
  • Chromatin (drug effects, ultrastructure)
  • DNA Damage (drug effects)
  • DNA, Neoplasm (analysis)
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (pathology)
  • Lipoxygenase Inhibitors (pharmacology)
  • Pyridines (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: